Inceptua Group and Cycle Pharmaceuticals partner for a Free Goods Programme for patients with Hereditary Tyrosinemia Type 1 (HT-1) and Alkaptonuria (AKU).
January 18, 2024
January 18, 2024
December 16, 2020
September 28, 2020
September 3, 2019
June 16, 2025
Fast Track granted for a next-generation, PARP1-selective inhibitor with CNS activity Addresses brain metastases harboring BRCA1/2 and/or HRR alterati...
June 11, 2025
Funding to drive development of permanent bioelectronic pacemaker following promising clinical data Ceryx Medical, a UK-based medtech innovator develo...
May 7, 2025
New Workflow Streamlines Protein Structural Analysis and Supports the Growing Role of AI in Drug Discovery GenNext® Technologies, Inc., a pioneer in p...
Life Science Newswire is a division of BioStrata Ltd, with company registered address: 3rd Floor, 1 Ashley Road, Altrincham, Cheshire, England, WA14 2DT. Company registration number: 8233225